Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care

综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学

• 批准号: 9793440
• 负责人: Bruce R Schackman
• 金额: $ 9.88万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-15 至 2020-07-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9793440
• 关键词: Address; Affordable Care Act; Alcohol or Other Drugs use; American; Award; Caring; Clinical; Clinical Trials; Collaborations; Communication; Consultations; Costs and Benefits; Data; Data Collection; Development; Discipline; Economics; Ensure; Environment; Feedback; Funding; Grant; HIV; HIV/HCV; Health; Health Insurance; Health Personnel; Health Promotion; Healthcare; Healthcare Systems; Hepatitis C Therapy; Hepatitis C virus; Individual; Infrastructure; Institution; Insurance Carriers; Insurance Coverage; Integrated Health Care Systems; Intervention; Leadership; Location; Mental Health; Mentors; Mentorship; Methodology; Methods; Observational Study; Online Systems; Organizational Models; Pattern; Persons; Pharmaceutical Preparations; Policies; Process; Provider; Research; Research Personnel; Research Project Grants; Research Support; Resources; Self-Examination; Services; Structure; Substance Use Disorder; System; Technology; Time; Training; Training Activity; Translating; United States National Institutes of Health; Work; advanced simulation; career development; clinically relevant; cohort; economic evaluation; economic impact; economic need; experience; health economics; improved; innovation; meetings; models and simulation; novel; outreach; parity; ranpirnase; research data dissemination; screening; service delivery; simulation; skills; sound; tool; training opportunity; treatment strategy

OVERALL PROJECT SUMMARY The US healthcare system is evolving towards a more integrated approach to improving the health of Americans. Greater availability of health insurance through the Affordable Care Act and new organizational models such as integrated healthcare systems are leading health care providers and insurers to consider the totality of costs and benefits, instead of focusing on costs and benefits of individual service delivery “silos.” For substance users, parity requirements for substance use disorder (SUD) and mental health insurance coverage and health insurance expansion present new opportunities for integrated care. They also present new opportunities and challenges for treating HCV-infected and HIV-infected substance users with highly effective and expensive medications. Both the broad societal economic impact and the health economic benefits for individuals of SUD, HCV, and HIV treatment need to be evaluated and communicated to clinical and policy decision makers in the context of this new environment. The overall specific aim of our P30 Center of Excellence proposal entitled “Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care” is to develop and disseminate economic evidence that informs substance use treatment policy and HCV and HIV care of substance users, and to increase the impact of this research by addressing the needs of integrated healthcare system providers and payers. Our proposed Center (CHERISH: Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV) includes Methodology, HCV and HIV, Dissemination and Policy, Pilot Grant and Training, and Administrative Cores, a Policy Advisory Board, and a Center Advisory Board. The Core leaders and investigators have extensive experience with multi-institutional collaborations and several previous and ongoing collaborations. They will draw on a wider circle of experts involved with each of the NIH-supported research projects. CHERISH will be led by an established national expert in SUD, HCV, and HIV health economic research who has substantial management experience. We will innovatively use web-based technology to supplement frequent in-person meetings and support a structured management process and administrative tracking system. The proposed Center will serve as a national SUD health economics research resource, furthering scientific collaborations among researchers, providing feedback to these researchers from stakeholders, and conducting outreach to clinical and policy decision makers. Such interaction between researchers and decision makers is essential for NIH-funded research on SUD treatment strategies to have its greatest impact. Through pilot grants and associated training activities, we will provide new opportunities for training, mentoring and career development for researchers in the field of SUD, HCV, and HIV health economics. These activities will yield a new cohort of investigators with the skills needed to conduct methodologically sound and innovative SUD economic research to inform SUD, HCV, and HIV treatment policy.

项目总体概要 美国医疗保健系统正在朝着更加综合的方法发展，以改善人们的健康 美国人通过平价医疗法案和新的组织结构获得更多的医疗保险 综合医疗保健系统等模式正在引领医疗保健提供者和保险公司考虑 成本和收益的总体，而不是关注单独服务交付“孤岛”的成本和收益。 物质使用者、物质使用障碍 (SUD) 的平价要求和精神健康保险覆盖范围 医疗保险的扩张为综合护理带来了新的机遇。 高效治疗 HCV 感染者和 HIV 感染者的机遇和挑战 和昂贵的药物。广泛的社会经济影响和健康经济效益。 SUD、HCV 和 HIV 治疗的个体需要进行评估并传达给临床和政策 我们 P30 中心的总体具体目标。 题为“药物使用障碍、丙型肝炎病毒和艾滋病毒治疗的健康经济学”的优秀提案 “综合医疗保健时代”旨在开发和传播为药物使用提供信息的经济证据 治疗政策以及物质使用者的丙型肝炎和艾滋病毒护理，并通过以下方式增加这项研究的影响： 满足综合医疗保健系统提供者和付款人的需求（珍惜： 药物使用障碍、丙型肝炎病毒和艾滋病毒治疗干预措施的健康经济学中心）包括 方法论、HCV 和 HIV、传播和政策、试点拨款和培训以及行政核心、 政策咨询委员会和中心咨询委员会拥有广泛的核心领导者和研究人员。 他们将拥有多机构合作以及之前和正在进行的多次合作的经验。 NIH 支持的每个研究项目都将吸引更广泛的专家参与。 由 SUD、HCV 和 HIV 健康经济研究方面的知名国家专家领导，他在 我们将创新性地利用基于网络的技术来补充频繁的面对面的管理经验。 会议并支持结构化管理流程和行政跟踪系统。 该中心将作为国家 SUD 卫生经济学研究资源，进一步促进科学合作 向研究人员提供来自利益相关者的反馈，并开展外展活动 研究人员和决策者之间的这种互动对于临床和政策决策者至关重要。 NIH 通过试点拨款和资助的 SUD 治疗策略研究产生最大影响。 相关培训活动，我们将提供新的培训、指导和职业发展机会 对于 SUD、HCV 和 HIV 健康经济学领域的研究人员来说，这些活动将产生一批新的人才。 具有进行方法合理且创新的 SUD 经济研究所需技能的调查人员 告知 SUD、HCV 和 HIV 治疗政策。